We aimed to (1) make a new variant of the protein-lipid complex at neutral pH for CML treatment and (2) elucidate the effect of the HALOA complex on the markers of apoptosis (total antioxidant capacity, IL-8, and survivin) on leukemia cells. This evidence concerns the gene BIRC5 and leukemia.